Malaysia Healthcare Travel Council (MHTC) marked the launch of Malaysia Healthcare Week Phnom Penh 2026 with a hospital introduction session in collaboration with OneHealth Cambodia. This engagement represents MHTC's first official initiative in Cambodia for 2026 and forms part of the Malaysia Year of Medical Tourism …
Eli Lilly and Company and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles t…
BD announced the successful completion of the previously announced spin-off of BD's Biosciences & Diagnostic Solutions business and the combination of the business with Waters Corporation . In connection with the transaction, BD shareholders will receive approximately 0.135 shares of Waters common stock for eac…
Azenta, Inc. announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space. This collaboration aims to harness the unique benefits of the microgravity environment to accelerate discovery and innovation in life scienc…
Cellares, the first Integrated Development and Manufacturing Organizatio, announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company…
Nanologica AB has entered into an agreement and completed the acquisition of all shares in Ardena Södertälje AB (“Syntagon”) from Ardena Sweden. The purchase price amounts to approximately SEK 8.6 million and will be paid in the form of newly issued shares in Nanologica. Syntagon is a Contract Development and Manufact…
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, today announced a strategic collaboration with Eli Lilly and Compa…
OXB , a global quality and innovation-led cell and gene therapy CDMO, announces it has expanded its strategic partnership with Bristol Myers Squibb , signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS' CAR-T programmes. This expanded partnership builds on the …
Jumo Health, a Patient Experience Organization, today announced a strategic partnership with Areti Health, an AI technology company, to advance the innovation and execution of PRISM™, Jumo Health's readiness-based clinical trial recruitment, enrollment, and retention system. PRISM was created to address a persistent …
SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, announced a global licensing agreement with Genentech, a member of the Roche Group, to advance one of its RNAi programs based on its proprietary RNAi platform. Under the agreement, SanegeneBio grants Genentech exclusive worldw…
Page 23 of 43